Navigation Links
drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007
Date:2/6/2008

e range of $2.9 million to $2.4 million, and adjusted EBITDA in the range of $1.9 million to $2.4 million. First quarter adjusted EBITDA guidance includes a $1.3 million investment in consulting services associated with profitability initiatives, which will result in improved margins throughout the remainder of 2008.

Financial and Operational Highlights for the Fourth Quarter of 2007

(All comparisons are made to the fourth quarter of 2006)

Key Financial Highlights:

-- Gross margins for the quarter increased 300 basis points to a record

high of 24.6%. For the year, gross margins improved 170 basis points

to 23.3%.

-- Total contribution margin dollars increased by over 30% for the quarter

and for the year improved by 20%.

-- Total orders grew by 9% to 1.6 million, while contribution margin

dollars per order grew almost 20% to approximately $13. For the year,

total orders increased by 10%, while contribution margin dollars per

order grew to approximately $12.

-- Cash, cash equivalents and marketable securities were $36.2 million at

year end.

Net Sales Summary:

-- Core OTC [1] revenues grew by approximately 18% to $65.4 million in the

quarter and increased by 19% to $232.4 million for the year.OTC net

sales grew by over 17% to $65.9 million. For the year, OTC net sales

grew by over 18% to $234.3 million.

-- Vision net sales grew approximately 6% to $12.7 million and for the

year increased over 10% to $54.9 million.

-- Local pick-up pharmacy net sales were up approximately 4% to

$26.9 million and for the year increased by approximately 6% to

$106.4 million.

-- Mail-order pharmacy net sales were down to $12.7 million. For the

year, mail order pharmacy net sales decreased 26% while contribution

margins dollars increased 10%.

-- Average net sales per
'/>"/>

SOURCE drugstore.com, inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007
2. drugstore.com, inc. to Announce Third Quarter 2007 Results During Conference Call on Monday, October 22, 2007 at 5:00 p.m. ET
3. drugstore.com and Revolution Health Group Announce Breakthrough Deal
4. TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
5. Joint Commission International Achieves Accreditation from ISQua
6. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
7. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
8. Pharsight Achieves $7.3 Million in Quarterly Revenue
9. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
10. LMS integrated obstetrics solution achieves general availability
11. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... August 01, 2015 , ... On Tuesday, July 28th, Symantec released a ... to have been behind the attack on Anthem Inc. which resulted in one of ... watering hole attacks and spear phishing campaigns. , For Joe Caruso, founder ...
(Date:7/31/2015)... ... July 31, 2015 , ... That’s right, the ... the STASH awards? The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, ... as tried-and-true products that have stood the test of time. These include lighting ...
(Date:7/31/2015)... ... 31, 2015 , ... Ticket Down is a reliable source for authentic tickets ... Grant Park. The festival will end on Sunday, August 2nd. , ... annual Lollapalooza. This unique and unbelievably popular festival attracts the best in entertainment ...
(Date:7/31/2015)... ... 2015 , ... Sculpted Contours Luxury Medical Aesthetics announces the arrival of the ... released this new applicator in the United States as an upgrade to the CoolSmooth ... The original applicator required a 2 hour treatment time. The new CoolSmooth Pro ...
(Date:7/31/2015)... ... ... M3 USA MDLinx.com, source of the Smartest Doc Board Exam Prep in ... The additions of Gastroenterology, Pulmonology and Allergy/Immunology round out an already robust selection of ... easy and painless. MDLinx offers thousands of board-exam style questions and exam-specific content ...
Breaking Medicine News(10 mins):Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3
... , THURSDAY, Sept. 24 (HealthDay News) -- Infants with ... a higher-than-normal rate of ear infections, a new study ... their backs to sleep has reduced cases of sudden ... infants with flattening of the back of the head, ...
... ... urgent medical conditions in homes and offices for the uninsured.,Launching in Chelsea, Sickday plans to ... ... York neighborhood will be a lot less expensive and more convenient thanks to Sickday ...
... September 24 , - ... (H1N1) and,Avian Influenza Viruses. , ... products and services, proudly announces the release of,Mandell, Douglas, ... Marking 30 years since its initial publication, it,remains the ...
... time researchers have shown that by inhibiting the action of ... cancer cells sensitive to chemotherapy, opening the way for the ... Dr Davide Melisi told Europe,s largest cancer congress, ECCO ... September) that resistance to chemotherapy was the greatest challenge to ...
... Doctors and ... Cleveland - can gain a new perspective on how to handle stress. , ... Cleveland (Vocus) September 24, 2009 -- Stress - we all ... other healthcare practitioners who attend a national educational conference - HOLISTIC HEALTH NOW Nov. ...
... Free Webinar Series...,On ... Make That Cost Them Plenty of Money, Time, Patients, and Lifestyle.... and on Oct 8 ... Marketing Strategies You,ve Been Hearing About. , ... Hickory, NC (PRWEB) September 24, 2009 -- Market Welby is hosting a free, ...
Cached Medicine News:Health News:Infant Head-Flattening Linked to Ear Infections 2Health News:Sickday Medical House Calls Launches Low Cost Neighborhood Service For Uninsured New Yorkers 2Health News:Sickday Medical House Calls Launches Low Cost Neighborhood Service For Uninsured New Yorkers 3Health News:30th Anniversary Edition of Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases is More Relevant Than Ever 2Health News:30th Anniversary Edition of Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases is More Relevant Than Ever 3Health News:30th Anniversary Edition of Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases is More Relevant Than Ever 4Health News:Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy 2Health News:Learn How to Treat Stress at HOLISTIC HEALTH NOW Conference Nov. 5-7 in Cleveland, Ohio 2Health News:Learn How to Treat Stress at HOLISTIC HEALTH NOW Conference Nov. 5-7 in Cleveland, Ohio 3Health News:Learn How to Treat Stress at HOLISTIC HEALTH NOW Conference Nov. 5-7 in Cleveland, Ohio 4Health News:Market Welby Hosting Free Urgent Care and Medical Practice Fast Growth Marketing Webinar Series 2
(Date:7/30/2015)... a special edition of #MedicareMonday on Medicare,s 50 th anniversary. As Medicare celebrates ... continue highlighting the success of the prescription drug benefit, commonly referred to as Part ... infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
(Date:7/30/2015)... THOUSAND OAKS, Calif. , July 30, 2015  Amgen ... Fred Hassan , partner and managing director of Warburg Pincus ... "We are pleased to welcome Fred Hassan and ... to the Amgen Board," said Robert A. Bradway , ... expertise and commitment to innovation will serve Amgen well." ...
(Date:7/30/2015)... VALLEY COTTAGE, New York , July 30, 2015 ... the release of its latest report titled, "Continuous Glucose ... 2015 - 2020". According to the report, the global ... 402.0 Mn in 2014 and is expected to reach ... 12.1% during the forecast period, 2015 to 2020. ...
Breaking Medicine Technology:Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
... SEATTLE, Feb. 10 Cell Therapeutics (CTI) (NASDAQ and ... definitive collaborative agreement with IDIS to manage its investigational ... Pixantrone will be supplied by IDIS to healthcare ... aggressive non-Hodgkin,s lymphoma. This program is expected to ...
... MONTREAL, Feb. 9 Sequoia Pharmaceuticals presented,positive ... in healthy volunteers and,preclinical studies on SPI-452, ... antiviral activity. Pharmacokinetic enhancers increase drug levels ... (CYP)-mediated,drug metabolism. These increased drug levels can ...
Cached Medicine Technology:Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone 2Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone 3Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone 4Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone 5Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 2Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 3Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 4Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 5
This multiple-function instrument allows the surgeon to grasp, coagulate, and transect tissue with a single instrument, eliminating the need for multiple instruments and, in some procedures, costly l...
Bipolar forceps...
... An in vitro Nucleic Acid ... using Microplate Chemiluminescence for the ... (HPV) Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 ... Lowand High-Risk Groups in Cervical ...
... superb radiation protection-0.62mm (+/- .05)Pb lead glass ... to their level of protection, they are ... smoothly on your bridge while hugging your ... wear corrective lenses, you can order Leaded ...
Medicine Products: